NON-CLEAR CELL RENAL CELL CARCINOMA (NCCRCC)

Clinical trials for NON-CLEAR CELL RENAL CELL CARCINOMA (NCCRCC) explained in plain language.

Never miss a new study

Get alerted when new NON-CLEAR CELL RENAL CELL CARCINOMA (NCCRCC) trials appear

Sign up with your email to follow new studies for NON-CLEAR CELL RENAL CELL CARCINOMA (NCCRCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1

Cancer patients get continued access to promising treatment in Long-Term study

Disease control Not yet recruiting

This study offers continued access to an experimental cancer treatment for up to 5,000 people who previously benefited from it in an Exelixis-sponsored trial. Participants must have a type of cancer such as kidney, liver, or pancreatic cancer and be deriving clinical benefit. The…

Matched conditions: NON-CLEAR CELL RENAL CELL CARCINOMA (NCCRCC)

Phase: PHASE3 • Sponsor: Exelixis • Aim: Disease control

Last updated Jun 17, 2026 02:57 UTC

NON-CLEAR CELL RENAL CELL CARCINOMA (NCCRCC)

Get alerted when new NON-CLEAR CELL RENAL CELL CARCINOMA (NCCRCC) trials appear

Cancer patients get continued access to promising treatment in Long-Term study